Source: Journal of Gastrointestinal Surgery. Unidade: FM
Subjects: MODELOS ANIMAIS, HAMSTERS, PANCREATITE (MÉTODOS), NEOPLASIAS PANCREÁTICAS, TERAPIAS COMPLEMENTARES
ABNT
MORIOKA, Cíntia Yoko et al. Farnesyltransferase inhibitor in hamster experimental pancreatic cancer model—Is it effective as neadjvant and adjuvant therapy?. Journal of Gastrointestinal Surgery, v. 9, n. 4, p. 616, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.gassur.2005.01.277. Acesso em: 06 out. 2024.APA
Morioka, C. Y., Matheus, A. S., Machado, M. C. C., Saito, S., Jukemura, J., Bacchella, T., et al. (2005). Farnesyltransferase inhibitor in hamster experimental pancreatic cancer model—Is it effective as neadjvant and adjuvant therapy? Journal of Gastrointestinal Surgery, 9( 4), 616. doi:10.1016/j.gassur.2005.01.277NLM
Morioka CY, Matheus AS, Machado MCC, Saito S, Jukemura J, Bacchella T, Arai H, Sakamoto T, Cunha JE, Watanabe A. Farnesyltransferase inhibitor in hamster experimental pancreatic cancer model—Is it effective as neadjvant and adjuvant therapy? [Internet]. Journal of Gastrointestinal Surgery. 2005 ; 9( 4): 616.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.gassur.2005.01.277Vancouver
Morioka CY, Matheus AS, Machado MCC, Saito S, Jukemura J, Bacchella T, Arai H, Sakamoto T, Cunha JE, Watanabe A. Farnesyltransferase inhibitor in hamster experimental pancreatic cancer model—Is it effective as neadjvant and adjuvant therapy? [Internet]. Journal of Gastrointestinal Surgery. 2005 ; 9( 4): 616.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.gassur.2005.01.277